135 related articles for article (PubMed ID: 38579649)
21. Impact of noncommunicable diseases on direct medical costs and worker productivity, Saudi Arabia.
Malkin J; Finkelstein E; Baid D; Alqunaibet A; Almudarra S; Herbst CH; Dong D; Alsukait R; El-Saharty S; Algwizani A
East Mediterr Health J; 2022 Apr; 28(4):296-301. PubMed ID: 35545911
[TBL] [Abstract][Full Text] [Related]
22. The economic burden of overweight and obesity in Saudi Arabia.
Malkin JD; Baid D; Alsukait RF; Alghaith T; Alluhidan M; Alabdulkarim H; Altowaijri A; Almalki ZS; Herbst CH; Finkelstein EA; El-Saharty S; Alazemi N
PLoS One; 2022; 17(3):e0264993. PubMed ID: 35259190
[TBL] [Abstract][Full Text] [Related]
23. Economic burden of depression in Brazil: a cost-of-illness study based on productivity losses and healthcare costs between 2010 to 2018.
Mercedes BPDC; Nunes da Silva E; Carregaro RL; Miasso AI
Expert Rev Pharmacoecon Outcomes Res; 2023 Feb; 23(2):181-189. PubMed ID: 36537181
[TBL] [Abstract][Full Text] [Related]
24. Health burden and costs of obesity and overweight in Germany.
Konnopka A; Bödemann M; König HH
Eur J Health Econ; 2011 Aug; 12(4):345-52. PubMed ID: 20401679
[TBL] [Abstract][Full Text] [Related]
25. Economic burden of childhood overweight and obesity: A systematic review and meta-analysis.
Ling J; Chen S; Zahry NR; Kao TA
Obes Rev; 2023 Feb; 24(2):e13535. PubMed ID: 36437105
[TBL] [Abstract][Full Text] [Related]
26. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
[TBL] [Abstract][Full Text] [Related]
27. Projected impact of population aging on non-communicable disease burden and costs in the Kingdom of Saudi Arabia, 2020-2030.
Boettiger DC; Lin TK; Almansour M; Hamza MM; Alsukait R; Herbst CH; Altheyab N; Afghani A; Kattan F
BMC Health Serv Res; 2023 Dec; 23(1):1381. PubMed ID: 38066590
[TBL] [Abstract][Full Text] [Related]
28. Estimating the healthcare cost of overweight and obesity in South Africa.
Boachie MK; Thsehla E; Immurana M; Kohli-Lynch C; Hofman KJ
Glob Health Action; 2022 Dec; 15(1):2045092. PubMed ID: 35389331
[TBL] [Abstract][Full Text] [Related]
29. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
30. Health and economic burden of sugar-sweetened beverages consumption in Brazil.
Perelli L; Alcaraz A; Vianna CMM; Espinola N; Cairoli FR; Bardach A; Palacios A; Balan D; Johns P; Augustovski F; Pichón-Rivière A
Cad Saude Publica; 2023; 39(12):e00249422. PubMed ID: 38126558
[TBL] [Abstract][Full Text] [Related]
31. Obesity and overweight in Canada: an updated cost-of-illness study.
Anis AH; Zhang W; Bansback N; Guh DP; Amarsi Z; Birmingham CL
Obes Rev; 2010 Jan; 11(1):31-40. PubMed ID: 19413707
[TBL] [Abstract][Full Text] [Related]
32. The economic burden of obesity in Italy: a cost-of-illness study.
d'Errico M; Pavlova M; Spandonaro F
Eur J Health Econ; 2022 Mar; 23(2):177-192. PubMed ID: 34347176
[TBL] [Abstract][Full Text] [Related]
33. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
[TBL] [Abstract][Full Text] [Related]
34. Burden of non-communicable diseases attributable to dietary risks in Brazil, 1990-2019: an analysis of the Global Burden of Disease Study 2019.
Machado ÍE; Parajára MDC; Guedes LFF; Meireles AL; Menezes MC; Felisbino-Mendes MS; Verly-Junior E; Malta DC
Rev Soc Bras Med Trop; 2022; 55(suppl 1):e0282. PubMed ID: 35107532
[TBL] [Abstract][Full Text] [Related]
35. Projecting Long-term Health and Economic Burden of COPD in the United States.
Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
[TBL] [Abstract][Full Text] [Related]
36. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
[TBL] [Abstract][Full Text] [Related]
37. The burden of overweight and obesity-related ill health in the UK.
Allender S; Rayner M
Obes Rev; 2007 Sep; 8(5):467-73. PubMed ID: 17716304
[TBL] [Abstract][Full Text] [Related]
38. Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil.
Nilson EAF; Metlzer AB; Labonté ME; Jaime PC
PLoS One; 2020; 15(7):e0235514. PubMed ID: 32645031
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of obesity-related chronic diseases in Mainland China.
Zhao W; Zhai Y; Hu J; Wang J; Yang Z; Kong L; Chen C
Obes Rev; 2008 Mar; 9 Suppl 1():62-7. PubMed ID: 18307701
[TBL] [Abstract][Full Text] [Related]
40. Health and economic burden of obesity in Brazil.
Rtveladze K; Marsh T; Webber L; Kilpi F; Levy D; Conde W; McPherson K; Brown M
PLoS One; 2013; 8(7):e68785. PubMed ID: 23874763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
